A novel treatment for embolising carotid dissection

Area of Science:

• Neurology
• Vascular Surgery

Background:

• Sub-intimal carotid dissection is a rare but significant cause of stroke, accounting for 2.5% of all strokes.
• It is the second leading cause of stroke in individuals under 45 and often results from neck trauma.
• Pathologically, it is attributed to thromboembolism, with microemboli in the middle cerebral artery being a risk factor for ischemic stroke.

Purpose of the Study:

• To report a case of symptomatic carotid artery dissection.
• To highlight the successful treatment of associated microemboli with Tirofiban.
• To suggest further investigation into Tirofiban's efficacy for microemboli post-carotid dissection.

Main Methods:

• A case report of a patient with symptomatic carotid artery dissection following radical neck dissection.
• Detection of microemboli using transcranial Doppler (TCD) examination.
• Treatment with Tirofiban, a potent intravenous antiplatelet agent.

Main Results:

• The patient presented with symptomatic carotid artery dissection.
• Microemboli were detected in the middle cerebral artery via TCD.
• Treatment with Tirofiban resulted in successful management of the microemboli.

Conclusions:

• Tirofiban demonstrated effectiveness in treating microemboli associated with carotid artery dissection.
• Further research is warranted to explore the use of Tirofiban in managing microemboli after carotid dissection.
• This case supports the potential role of Tirofiban in improving outcomes for patients with carotid dissection-related microemboli.